BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 1926144)

  • 1. Triethylene-tetramine (trien) therapy for Wilson's disease.
    Saito H; Watanabe K; Sahara M; Mochizuki R; Edo K; Ohyama Y
    Tohoku J Exp Med; 1991 May; 164(1):29-35. PubMed ID: 1926144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Wilson's disease treatment by triethylene tetramine dihydrochloride (trientine, 2HCl): long-term observations.
    Morita J; Yoshino M; Watari H; Yoshida I; Motohiro T; Yamashita F; Okano Y; Hashimoto T
    Dev Pharmacol Ther; 1992; 19(1):6-9. PubMed ID: 1307347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of Wilson's disease with trientine (triethylene tetramine) dihydrochloride.
    Walshe JM
    Lancet; 1982 Mar; 1(8273):643-7. PubMed ID: 6121964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of Wilson's disease with triethylene tetramine hydrochloride (Trientine).
    Dubois RS; Rodgerson DO; Hambidge KM
    J Pediatr Gastroenterol Nutr; 1990 Jan; 10(1):77-81. PubMed ID: 2324883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mode of action of triethylenetetramine dihydrochloride on copper metabolism in Wilson's disease.
    Siegemund R; Lössner J; Günther K; Kühn HJ; Bachmann H
    Acta Neurol Scand; 1991 Jun; 83(6):364-6. PubMed ID: 1887758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Copper chelation in patients with Wilson's disease. A comparison of penicillamine and triethylene tetramine dihydrochloride.
    Walshe JM
    Q J Med; 1973 Jul; 42(167):441-52. PubMed ID: 4728043
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of Wilson's disease with triethylene tetramine dihydrochloride. A case report.
    Haslam RH; Sass-Kortsak A; Stout W; Berg M
    Dev Pharmacol Ther; 1980; 1(5):318-24. PubMed ID: 7438976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Wilson's disease.
    Ala A; Walker AP; Ashkan K; Dooley JS; Schilsky ML
    Lancet; 2007 Feb; 369(9559):397-408. PubMed ID: 17276780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pattern of urinary copper excretion and its response to treatment in patients with Wilson's disease.
    Walshe JM
    QJM; 2011 Sep; 104(9):775-8. PubMed ID: 21622540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A study of trientine therapy in Wilson's disease with neurological symptoms].
    Suda M; Kubota J; Yamaguchi Y; Fujioka Y; Saito Y; Aoki T
    No To Hattatsu; 1993 Sep; 25(5):429-34. PubMed ID: 8398232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Practical recommendations and new therapies for Wilson's disease.
    Brewer GJ
    Drugs; 1995 Aug; 50(2):240-9. PubMed ID: 8521757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pathogenesis and treatment of Wilson's disease].
    Nagy J; Vincze Z; Folhoffer A; Horváth A; Csák T; Zelkó R
    Acta Pharm Hung; 2003; 73(4):237-41. PubMed ID: 15279036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term treatment of Wilson's disease with triethylene tetramine dihydrochloride (trientine).
    Dahlman T; Hartvig P; Löfholm M; Nordlinder H; Lööf L; Westermark K
    QJM; 1995 Sep; 88(9):609-16. PubMed ID: 7583074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of Wilson's disease: what are the relative roles of penicillamine, trientine, and zinc supplementation?
    Schilsky ML
    Curr Gastroenterol Rep; 2001 Feb; 3(1):54-9. PubMed ID: 11177695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Penicillamine and the SLE syndrome.
    Walshe JM
    J Rheumatol Suppl; 1981; 7():155-60. PubMed ID: 6939878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Wilson's disease with severe neurological manifestations: response to trientine plus zinc therapy].
    Serra B; Primo J; García M; Amorós I; Aragó M; Merino C
    Gastroenterol Hepatol; 2004 May; 27(5):307-10. PubMed ID: 15117609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolism of administered triethylene tetramine dihydrochloride in humans.
    Kodama H; Murata Y; Iitsuka T; Abe T
    Life Sci; 1997; 61(9):899-907. PubMed ID: 9284083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discontinuation of penicillamine in the absence of alternative orphan drugs (trientine-zinc): a case of decompensated liver cirrhosis in Wilson's disease.
    Ping CC; Hassan Y; Aziz NA; Ghazali R; Awaisu A
    J Clin Pharm Ther; 2007 Feb; 32(1):101-7. PubMed ID: 17286794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The treatment of Wilson's disease, a rare genetic disorder of copper metabolism.
    Purchase R
    Sci Prog; 2013; 96(Pt 1):19-32. PubMed ID: 23738435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical presentation, diagnosis and long-term outcome of Wilson's disease: a cohort study.
    Merle U; Schaefer M; Ferenci P; Stremmel W
    Gut; 2007 Jan; 56(1):115-20. PubMed ID: 16709660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.